Pillay-Fuentes Lorente, Veshni https://orcid.org/0000-0001-5365-0320
Nwogu-Attah, Jacinta N. https://orcid.org/0000-0002-0640-7165
Steffens, Britta https://orcid.org/0009-0002-2259-4180
Bräm, Dominic https://orcid.org/0000-0001-9094-8361
Sprecher, Viviane https://orcid.org/0000-0002-1558-6687
Hofmann, Daniela https://orcid.org/0000-0001-7073-0744
Buettcher, Michael
Pillai, Goonaseelan https://orcid.org/0000-0002-5658-3837
Mouksassi, Samer
Coulibaly, Jean
Pfister, Marc https://orcid.org/0000-0003-2597-1228
Keiser, Jennifer https://orcid.org/0000-0003-0290-3521
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1153928)
Article History
Accepted: 23 June 2024
First Online: 22 July 2024
Declarations
:
: This project was conducted as part of the Applied Pharmacometrics Training Fellowship, a capacity strengthening program organised by Pharmacometrics Africa NPC and Certara. Fellows contributed equally to the work presented here. Jennifer Keiser is grateful to the Bill and Melinda Gates Foundation (OPP1153928) and the Swiss National Science Foundation (320030_175585 1) for financial support.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: Ethics approval was obtained from the independent ethics committees in Côte d’Ivoire (reference numbers 088–18/MSHP/ CNESVS-km and ECCI00918), Laos (reference number 093/NECHR), Tanzania (Zanzibar, reference number ZAMREC/0003/Feb/2018), and Switzerland (reference number BASEC Nr Req-2018-00494).
: All participants gave written informed consent to participate in the study.
: Not applicable.
: Data will be made available on reasonable request.
: Not applicable.
: Acquisition: VS, JC, DH. Analysis and interpretation of the data: VPFL, JN, BS, DB, GP, SM, MC, JK. Drafting of manuscript: VPFL JN, BS, DB. Critical revision of the manuscript: VS, DH, MB, GP, SM, JC, MP, JK.